iShares Biotechnology ETF IBB
213.92 USD +3.92 (+1.87%)
Nov 6, 2026, 2:40 PM EST
208.68 Day range 214.97
154.98 52-week range 222.29
- YTD
- +26.75%
- 1 year
- +35.02%
- Market cap
- 10.86B
- EPS (ttm)
- 8.55
- P/E ratio
- 25.02
- Dividend yield
- 0.16%
- YTD return
- +26.75%
- 1-year return
- +35.02%
- Volume
- 1.73M
- Avg volume
- 1.71M
- Open
- 208.78
- Previous close
- 209.99
- Day's range
- 208.68 – 214.97
- 52-week range
- 154.98 – 222.29
5m -4.32 (-1.98%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 208.49
- 200-day average
- 185.19
Next earnings
Consensus EPS estimate 0.00.
About iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
News
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
$10,000 in Vanguard's Health Care ETF in 2004 Grew to $93,915, and It Still Charges 0.09%
Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street
Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs
Dow Jones Climbs to 52,000 While Chips Bleed on Rate-Hike Fears: Stock Market Today
Nasdaq 100 Drops 1% on Hot CPI, SOXX Falls 7th Day: Stock Market Today
Stock Market Today: S&P 500, Russell 2000 Fall as 30-Year Yield Hits 5.7%
S&P 500, Nasdaq Hit Records, Power Stocks Rally on Google's Nuclear Deal: Stock Market Today
S&P 500 Erases Losses as US, Iran Reportedly Discuss Hormuz Deal: Stock Market Today
Nasdaq 100 Flirts with Records, Oil Sinks for Fifth Day: Stock Market Today
Your note
Sign in to keep a note on IBB — it syncs with the Stock Master app.
